The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of chemoradiation therapy (nab-paclitaxel/Gemcitabine) in 15 patients with unresectable locally advanced pancreatic cancer (UR-LAPC).
 
Hironari Sueyoshi
No Relationships to Disclose
 
Tatsuya Ioka
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst); Merck Serono (Inst); Taiho Pharmaceutical (Inst); Zeria Pharmaceutical (Inst)
 
Takeshi Tamura
No Relationships to Disclose
 
Ryoji Takada
No Relationships to Disclose
 
Nobuyasu Fukutake
No Relationships to Disclose
 
Reiko Ashida
No Relationships to Disclose
 
Kazuyoshi Ohkawa
No Relationships to Disclose
 
Hidenori Takahashi
No Relationships to Disclose
 
Teruki Teshima
No Relationships to Disclose
 
Kazuhiro Katayama
No Relationships to Disclose